Hongqian Wu
-
- Cancer Immunotherapy and Biomarkers 4
- Pancreatic and Hepatic Oncology Research 2
- Colorectal Cancer Treatments and Studies 1
- CAR-T cell therapy research 1
-
- Advanced Breast Cancer Therapies 2
-
- Esophageal Cancer Research and Treatment 2
-
- Protein Kinase Regulation and GTPase Signaling 1
-
- Neuroendocrine Tumor Research Advances 1
- Co-authors
- Jason E. FarisMatthew H. TaylorScott B. CameronChia‐Chi LinMarcus O. ButlerAndréa VargaHans GelderblomJan H.M. Schellens
- Partner nations
- United StatesSpainSwitzerland
In The Last Decade
Hongqian Wu
6 papers receiving 120 citations
Peers
Comparison fields: 5 of 28
- Oncology 93
- Endocrinology, Diabetes and Metabolism 34
- Immunology 29
- Pathology and Forensic Medicine 16
- Pulmonary and Respiratory Medicine 28
Countries citing papers authored by Hongqian Wu
This map shows the geographic impact of Hongqian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongqian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongqian Wu more than expected).
Fields of papers citing papers by Hongqian Wu
This network shows the impact of papers produced by Hongqian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongqian Wu. The network helps show where Hongqian Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongqian Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2020 | 8 | |
| 4 | 2020 | 63 | |
| 5 | 2018 | 37 | |
| 6 | 2018 | 11 |
About Hongqian Wu
Hongqian Wu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 6 papers that have together received 121 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (2 papers), Advanced Breast Cancer Therapies (2 papers), Esophageal Cancer Research and Treatment (2 papers), Protein Kinase Regulation and GTPase Signaling (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (93 citations), Endocrinology, Diabetes and Metabolism (34 citations) and Immunology (29 citations). Hongqian Wu has collaborated with scholars based in United States, Spain and Switzerland. Frequent co-authors include Jason E. Faris, Matthew H. Taylor, Scott B. Cameron, Chia‐Chi Lin, Marcus O. Butler, Andréa Varga, Hans Gelderblom, Jan H.M. Schellens, Sunil Sharma and Aung Naing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.